Fulgent Genetics (FLGT) Free Cash Flow (2015 - 2026)

Fulgent Genetics has disclosed Free Cash Flow across 12 years of filings, most recently posting $1.9 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at $1.9 million, up 120.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$113.2 million (down 257.97% YoY), and the FY2025 annual result was -$124.2 million, down 545.09% from the prior year.
• Free Cash Flow came in at $1.9 million for Q1 2026 at Fulgent Genetics, up from -$98.6 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $183.1 million in Q1 2022 to a low of -$98.6 million in Q4 2025.
• The 5-year median for Free Cash Flow is $3.2 million (2024), against an average of $5.8 million.
• Across the five-year window, Free Cash Flow soared 247.82% in 2024 and slumped 887.91% in 2025, its largest moves.
• Fulgent Genetics' Free Cash Flow stood at $28.5 million in 2022, then slumped by 58.48% to $11.8 million in 2023, then tumbled by 208.3% to -$12.8 million in 2024, then sank by 670.13% to -$98.6 million in 2025, then soared by 101.92% to $1.9 million in 2026.
• The last three Free Cash Flow figures came in at $1.9 million (Q1 2026), -$98.6 million (Q4 2025), and $11.6 million (Q3 2025), per Business Quant data.